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Abstract:

Hypoxia is a condition of inadequate oxygen supply. Adaptive responses can be
developed by cells that undergo hypoxic conditions. To understand human hypoxic responses,
our lab generated a human hypoxic neuronal cell model system using the hypoxic mimicking
compound, Desferoxamine (DFO), to simulate hypoxic condition. We found that DFO treatment
decreased cell viability. However, some cells still survived. Using confocal image analysis the
surviving cells were morphologically similar to control (vehicle-treated) cells. These surviving
cells developed the adaptive responses, such as the decrease of human mu opioid receptor
(hMOR) message level and the increase of hypoxia inducible factor I (HIP-I) mRNA level by
RT-PCR analysis. Additionally the level of human delta opioid receptor (hDOR) message was
not changed, whereas, the human kappa opioid receptor (hKOR) message level was up regulated
in these surviving neurons. Therefore, this study was to first investigate if hKOR protein levels
increased under hypoxia. The results of radioisotope ligand binding-assay showed that 48 hour
DFO treatment resulted in the increase ofhKOR protein levels. To further examine if the HIF
response element located at the hKOR promoter region was responsible for the increase of
hKOR message level, four putative HIF-I response elements from the hKOR gene were cloned
into the pGL3-promoter vector, a plasmid containing the luciferase reporter gene. Using transient
transfection with human Neuorblastoma (NMB) cells, the preliminary results showed that several
HIF responsive elements are involved in the up-regulation ofhKOR message under DFO
simulated hypoxic condition.

VI

Introduction

Hypoxia:

Oxygen is essential for cell survival; therefore, tissue oxygenation is essential for all
nonnal physiological functions, including but not limited to, cell growth, respiration, and
metabolism. However, medical conditions such as cardiac arrest, asthma, pneumonia, and stroke
cause the body to be deprived of adequate oxygen or a condition called hypoxia. Additionally,
hiking at high altitudes, diving underwater, and extensive athletic training can cause hypoxic
conditions in the body. In tum, hypoxia can be defined as the deficiency in the bioavailability of
oxygen to the tissues of the body (Loiacono, et aI., 2010). Connett and colleagues define in
theory three thresholds of cell hypoxia (Connett et aI., 1990).
1. The first threshold is when cellular oxygen decreases but adenosine triphosphate (ATP)

production is maintained at level sufficient to match ATP demand by metabolic adaptation.
2. The second occurs when steady state ATP turnover can be maintained only by the production
ofATP from anaerobic glycolysis by the Embden-Meyerhofpathway. This pathway generates
only 2 molecules of ATP per 1 molecule of glucose metabolized. For highly metabolic tissues
such as the kidney, liver, and brain, anaerobic glycolysis is too cumbersome to be effective and
these organs develop ATP depletion rapidly under hypoxic conditions.
3. The last threshold is when glycolysis becomes insufficient to produce enough ATP to maintain
cell function and structural integrity.
Many tissues after the second threshold develop ATP depletion. One of these tissues is
the brain; nerve cells in the brain require high levels of ATP to operate the sodium-potassium
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pump. When 50-60% of ATP is lost due the decrease levels of oxygen, depolarization of the
membrane and uptake of sodium and water occurs (Loiacono et aI., 2010). Depolarization results
in an influx in calcium through voltage-gated calcium channels, and leads to glutamate
neurotransmitter release (Cook et aI, 2010). Glutamate binds to glutamate receptors, initiating a
process of calcium influx and excitatory injury called the glutamate cascade (Dendorfer et al.,
2005). The death of neurons from these insults can follow quickly in by swelling and lysing, or
through a complex process resembling apoptosis (Dendorfer et aI., 2005). However, many
studies have shown that some neuronal cells under hypoxic conditions do survive (Cook et aI.,
2010). These surviving cells develop adaptive responses, and express high levels of hypoxia
inducible factor 1a (HIF-1a) (Chavez et aI., 2006), which is a transcription factor and a major
regulator of the cellular response to hypoxia (Semenza, 2000).

Hypoxia Inducible Factor 1 (HIF-l)

In mammalian cells, HIF -1 has been shown to play an essential role in the cellular and
systemic oxygen homeostasis (Lee et aI., 2003). HIF -1 has been considered to be a master
transcriptional regulator in hypoxia (Yan et aI., 2011) and be a key modulator for the induction
of genes that facilitate adaption and survival of cells (Ke et aI., 2006). The genes targeted by
HIF-1 include vascular endothelial growth factor (VEGF) that is involved in angiogenesis
(Conway et al., 2001), insulin-like growth factors (IGF) (Krishnamachary et aI., 2003), and
transforming growth factors (TGF) (Semenza, 2003). These genes can activate signal
transduction pathways, which lead to cell proliferation and survival (Lee et aI., 2003).
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HIF-l is a heterodimer complex that consists of a hypoxic inducible subunit HIF-la and
a constitutively expressed subunit HIF -I ~ also known as the aryl hydrocarbon receptor nuclear
translocator (ARNT) (Ke et aI., 2006, Lee et aI., 2003). These proteins belong to the basic helix
loop-helix- Per-ARNT-Sim (bHLH-PAS) protein family (Wang et aI., 1995). HIF-la subunit
stability can be affected by oxygen levels. The a subunit contains two PAS and bHLH domains~
which are required for heterodimerzing of alpha and beta subunits and for binding to DNA (Lee
et aI., 2003). It also contains two transactivation domains N-terminal (N-TAD) and C-terminal
(C-TAD). The C-TAD terminal has been shown to interact with CBP/p300 coactivators to
activate gene transcription (Ke et aI., 2006, Le et aI., 2003).
The other important domain that mediates oxygen regulated stability is the oxygen
dependent degradation domain (ODDD) (Pugh et aI., 1997). During normal conditions, HIF -1 a
has a short half-life of 5 minutes. In normoxia, hydroxylation of two proline residues Pro 402,
and Pro 564 within the ODDD regions mediated by prolyl4-hydroxylase (PHD) (Masson et aI.,
2001), and the acetylation of lysine residue Lys 532 by acetyl transferase arrest-defective-l
(ARD1) promote the interaction with an ubiquitin E3 ligase complex Von Hippel-Lindau
(pVHL) (Jeong et aI., 2002). This in-tum marks HIF-la for degradation by the 26S proteasome.
At the same time, the hydroxylation of asparagine residue Asn 803 in the C-TAD of HIF-1 a by
FIH-l prevents the interaction ofHIF-la to CBP/p300 (Lando et aI., 2002).
However, during a hypoxic condition, activities of PHD and FIH-l are inhibited, which
results in no proline and asparagine hydoroxylation. Thus, there is no VHL binding and HIF-la
is stabilized. HIF-la translocates to the nucleus and forms a heterodimer with HIF-I~, which
then recruits CBP/p300 co-activators and enhances the gene transcription. These targets genes
are related to erythropoiesis/iron metabolism, angiogenesis, vascular tone, glucose metabolism,
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cell proliferation/survival, and apoptosis (Lee et aI., 2003; Ke et aI., 2006; Jeong et aI., 2002).
HIF-l plays a major role in oxygen sensing system that governs cellular response to decrease
levels of oxygen (Schoolmeesters et aI., 2012).
In previous studies, HIF-l has been shown to offer protection to neuronal cells under
hypoxic insult using animal model systems. In the ischemic rat brain, HIP-l increased VEGF
gene expression, which then increased blood-brain barrier permeability, and may offer
neuroprotection (Yan et aI., 2011). In astrocytes of rats, an increase of HlF-l increased glucose
uptake (Valle-Casuso et aI., 2012). By exposing 14 day old embryonic mice to hyoxia
reperfusion injury, HIF-lu provided neuronal protection (Vangeison et aI., 2008). Moreover,
using the hypoxic pre-conditional mouse model, the induction ofHIF-l and its target genes
offered therapeutic potential (Ferriero, 2005).
Therefore, to study the hypoxic response of human neurons, human neuroblastoma cell
lines are commonly used as models (Jogi et aI., 2004). In the human NMB cells, hypoxia
stabilizes HIF-lu proteins and activates expression of known hypoxic induced genes, such as
erythropoietin, VEGF, IGF, TGF which are associated with cell metabolism or cell
proliferation/survival (Mannello et al., 2011; Krishnamachary et aI., 2003; LeCouter et aI.,
2001).
Previously, we generated a hypoxic cell model system, using human neuronal NMB cells
with the hypoxic mimicking compound desferoxamine (DFO) (Cook et aI., 2010).
Approximately 60% of neuronal cells survived under chemically induced hypoxic conditions
(Figure 1) (Cook et aI., 2010). Using annexin-V-FLUOS and propidium iodide staining (Figure
2), the surviving cells did not show any significant morphological change as compared to the
control cells using confocal microscopy analysis. This proves that cells were not at the apoptotic
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or necrotic stages (Cook et aI., 2010). Furthermore, using RT-PCR, HIF-1 rnRNA levels
increased after 24 hours (Figure 3) (Cook et aI., 2010). These data demonstrated that surviving
neuronal cells did develop the adaptive responses, and can be used as a human hypoxic cell
model system.

Opioid Receptors:

The NMB cell line also contains various types of opioid receptors, which have been
suggested to playa role in neuronal cell death and survival (Tegeder et aI., 2004). In mammalian
cells there are three types of opioid receptors Mu, Kappa, and Delta (Waldhower et aI., 2004).
They are G protein coupled receptors embedded in the plasma membrane of neurons
(Waldhower et aI., 2004). When receptors are bound by a ligand, the associated G protein is
activated and further activates the 2nd messenger systems (Minami et aI., 1995), which then can
alter protein phosphorylation via the kinases and/or alter gene transcription (Waldhower et aI.,
2004).
Previous studies have shown that treatment with Delta opioid receptor (DOR) agonist
enkephalin led to neuroprotection in hypoxic conditions (Ma et aI., 2005). Treatment with Kappa
opioid receptor (KOR) agonist U-50488 offered neuroprotective effects to mice in ischemic
environment (Schunk et aI., 2011), and preconditioning with Mu opioid receptor (MOR) agonist
morphine reduced neuronal death of rat cells in ischemic condition (Zhao et aI., 2006). However,
there are also opposite results found in the literature. It has been shown that DOR agonist did not
offer protection against moderate and mild ischemia in rat brain (Iwata et aI., 2007).
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Furthermore, MOR and KOR did not protect neocortical neurons against ischemic injury (Zhang
2000).

In addition, opioid receptors are also known to modulate the sense of pain (Schunk et aI.,
2011; Zhao et aI., 2006). Stroke, trauma, and cardiac arrest cause hypoxic conditions and can
also cause pain in the body (Schunk et aI., 2011). Therefore, using the human neuronal NMB
hypoxic model system, our lab also found that there was a reduction ofMOR mRNA message
compared to the control (Figure 4A), and no significant changes were observed for DOR mRNA
expression (Figure 4B) using RT-PCR (Cook et al., 2010). In addition, KOR mRNA expression
showed a significant increase in the surviving cells (Karch et al., lab unpublished data). These
results indicated; that opioid receptors may have a role in cell survival.

Hypoxic mimicking compound

To generate hypoxic condition, cells can be incubated in a hypoxic chambers or the usage
of chemical compounds that induces hypoxic mimic conditions. These compounds include
ophenanthroline, iodochlorohydroxyquinoline, cobalt sulfate heptahydrate, and DFO (Xia et aI.,
2009; Ryter et aI., 2000; Saini et al., 2009). DFO has been commonly used in hypoxia related
research, and it is an iron chelator; it chelates the iron in the PHD region ofHIF-la that is
loosely bound by 2-histidine-l-carboxylate coordination motif. By diminishing the availability of
iron, HIF-la is stabilized because the prolyl-4-hydorxylase requires oxygen, iron and ascoarbate
as cofactors (Ke et al., 2006); therefore, DFO can activate downstream responses similar to
hypoxic condition (Bartolome et aI., 2008). In animal models, DFO induced hypoxia-like
adaptive changes in the host (Dendorfer et aI., 2005; Hamrick et aI., 2005; Prass K et aI., 2002).
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DFO has been shown to increase HIF-la expression in mice and rats neuronal cells (Jaakkola et
aI., 2001; Pichiule et aI., 2007).

Goal

Our previous studies using NMB hypoxic model system have shown an increase ofHIF
la mRNA levels, and an increase in hKOR messenger level using RT -peR analysis. This study
is therefore to investigate if (1) the change of mRNA level resulted in the changes of protein
levels of opioid receptors, and (2) ifHIF-la mediated the mRNA change ofhKOR in the same
cell model system.
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Figure 1: The effect ofDFO NMB cells, cel1s were treated with DFO in 2, 4, and 24hrs, and cell
viability and GST levels were measured (Cook et ai., 2010).
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Methods and Materials:

Cell Culture:

Human Neuroblastoma cells were grown in Roswell Park Memorial Institute Medium (RPM!)
1640 containing 10% heat inactivated Fetal Bovine Serum (FBS). The cells were cultivated in
tissue culture flasks (Fisher Scientific, Tunsitn, CA) in an atmosphere of 5% C02 and 95% air at
37°C incubator.

Plasmid Construction:

The region containing the potential IDF response element were generated by PCR using Imin at
95°C, 30 sec at 60°C and 30 sec at 72°C. The PCR products were then cloned into pCR2.1 vector
(Life Technologies, Grand Island, NY). The inserts with correct sequences were then sublconed
into pGL3 promoter vector (Promega, Madison, WI) that contains a luciferase reporter gene. The
subcloned plasmids were then digested using Xhol and Asp718 (Promega, Madison, WI) to
verify the presence of the insert. The plasm ids containing correct sequences were then used for
further study.
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Transient Transfection:

Cells were plated in 6 well plates and then were transiently transfected using Effectene
Transfection reagent (QIAGEN, Valencia, CA). Twenty-four hours after transfection, cells were
treated with 300 J!M DFO for 24 hours treatments. After treatment cells harvested and lysed with
lysis buffer (Promega, Madison, WI). Luciferase activity was determined following
manufacturer procedure (Promega, Madison, WI) using luminometer (Berthold).

Membrane Preparation:

Cells were harvested with PBSIEDTA and then homogenized in 25 mM HEPES, pH 7.4,
containing 0.32 M sucrose, and protease inhibitors phenylmethylsulfonylflurodie (PMSF),
sodium orthovanadate, aprotinin, and pepstatin. Celllysates were then centrifuged at 3000 rpm
for 10 minutes at 4°C, and supernatant was collected. Next, supernatant was centrifuged at
24,000 rpm for 60 minutes at 4°C, The pellet was resuspended in 25mM HEPES, pH 7.4 and was
ready for use. The protein concentration was determined using Lowry assay.

Radioisotope Ligand Binding-Assay:

Cell membranes (400 ug) were incubated with the H3 diprenorphine in the absence or presence
of 1 J!M unlabeled opioid agonists- Mu-Damgo, Delta-Daddle, and Kappa-U-50 in 25 mM
HEPES buffer, pH 7.4 for 60 minutes at room temperature in a final volume of 1 ml. The
reaction was stopped by filtration through filters. The filters were washed two times with 1 ml of
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cold 25 mM HEPES. pH 7.4. Then the filters were equilibrated with ScintiVerse-BD (Fisher.
Tunsiten. CA) before assaying in the beta counter.
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Results

Examining the protein expression of hKOR in NMB cells

Previously, in our lab DFO induced hypoxic mimic responses were investigated using the
human neuronal NMB cell lines (Cook et aI., 2010). Using this cell model system, we found that
some neuronal cells survived under DFO treatment, and the level ofHIF messages was
increased, and the hMOR messages were also decreased in these surviving cells (Cook et aI.,
2010). RT-PCR analysis further showed an increase ofhKOR mRNA expression in these
surviving NMB cells (Karch et aI., unpublished data). Therefore, the logical next step was to
examine if hKOR protein levels also increased under the treatment.
The receptor-ligand binding-assay was then carried out using the membrane preparations
from NMB cells with the radioisotope-labeled ligand, 2nM H3-dipemorphine, 1J.1M U-50488 as
the cold competitive ligand. There are three opioid receptors, mu, delta, and kappa found in
NMB cells. Therefore, to block mu and delta receptor binding, 1J.1M ofDAMGO and DADLE
were also included in every reaction. In Figure 5, the results indicated that the 48 hour treated
group showed a significant increase (around 2-fold), however, the 24 hour treatment did not
result in a significant increase as compared to the control group, suggesting that there is a lag
between the changes of mRNA level and the changes of protein level. Overall, this data
suggested that hKOR protein level is significantly increased at 48 hours ofDFO treatment.
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Plasmid Construction of bKOR promoter region:

To further investigate if the HIF-I is involved in the increase ofhKOR mRNA level in
this cell model system, the luciferase reporter assay was chosen. First the plasmid construction
was performed by cloning the putative HIF responsive elements of the hKOR promoter region
into pGL3-promoter vector. There are a total of 4 putative HIP responsive elements in the 5'
flanking region ofhKOR gene, which are designated as A (the far one from the gene), B, C and
D (The closest one). Each of these DNA fragments containing the putative HIF response
elements was generated by PCR method. The PCR products were then cloned into pCR2.1 vector
(Fig. 6A). The E. coli competent cells were then transformed using the ligation mixture with
heat-shock method. The transformed bacteria were then selected under the ampicillin containing
plates. The plasmid was then purified from the individual colony, and each plasmid was verified
by restriction enzymes digestion. Each digested sample was then examined using 2% agarose gel
to check for the presence ofthe cloned insert.
The clones with the insert were then subjected to DNA sequencing. An insert with the
correct sequence was then sub-cloned into pGL3-promoter vector (Fig. 6B), which contains the
luciferase reporter gene. The similar screening processes for various clones were used (as
described above). Figure 7A, shows a representative gel screening of clone A, Fig 7B for clone
B, 7C for clone C, and 7D for clone D. The plasmids contained the inserts were subjected to
sequencing again. The plasm ids with the correct sequences were then subjected to large scale
plasmid purification.
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Examining the function of putative HIF-l responsive elements using the luciferase reporter
assay

To detennine the functional role of these putative HIF responsive elements, NMB cells
were transiently transfected with the pGL3 promoter-Iuciferase reporter gene and HIF expression
vector. Each set contained a negative control plasmid, a blank pGL-3 promoter vector (P). After
transfection, cells were treated with DFO for 24 hours. The cells were then harvested and lysed.
The luciferase activity was then detennined.
The preliminary data from the luciferase assay (Fig. 8) showed that A and C had a slight
increase and B show no difference ofluciferase activity after 24 hours ofDFO treatment.
However, D showed the strongest increase in expression among the 4 putative elements. The
result indicated that A, C, and D regions increase in expression after 24 hours ofDFO treatment.
In addition, we also obtained a clone plasmid containing 2 copies ofHIF responsive
element D (2-D). The luciferase activity of this plasmid was also examined using the same
procedure as previously described. Fig. 9 showed that the 2-D plasmid had a very strong
response under the treatment indicating that HIF responsive element in the D region may play an
important role under hypoxic condition.
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Discussion

The aim of this study was first to investigate the change of opioid receptor protein levels
under hypoxia, and secondly to examine ifHIF mediated the mRNA change ofhKOR level in
NMB hypoxic cell model system. This study showed that hKOR protein levels increased at the
48 hour treatment and HIF mediated the increase ofhKOR expression in this hypoxic cell model
system.
The increase ofhKOR mRNA level was detected after 24 hours ofDFO treatment (Karch
et aI., unpublished data). However, the change ofhKOR protein level was not detectable at 24
hour treatment using the receptor-ligand binding assay, although there was about 2-fold increase
at the 48 hour treatment. One of the possibilities is the limitation of both protein and mRNA
experiments, therefore proper correlation is not observed
An increase ofhKOR expression was shown in this study, but do they offer

neruoprotection in hypoxic condition? There are reports that have shown that hKOR offers
neuroprotection in hypoxic conditions (Schunk et aI.,

2011~

Zeynalov et aI., 2000). It has been

shown that the treatment with KOR agonist BRL 52537 provides a long therapeutic window
against ischemia in rats (Zeynalov et aI., 2006). As well as in mice brain, preconditioning with
KOR agonist U-69593 has offered protection against seizures, furthermore, using a KOR
antagonist nor-BNI did block the protection indicating that activation ofKOR may mediate
neuroprotective effect (Rubaj et aI., 2000)). However, there are also opposite reports, in a study
using ischemic rats~ KOR did not offer any neuroprotection (Zhang et aI., 2000). Whether KOR

23

can provide neuroprotection against hypoxia in this NMB cell model system, will be examined in
the near future.
HIF-I is a transcriptional regulator of hypoxia (Ke et aI., 2006). Our preliminary results
using the luciferase reporter assay showed that several HIF response regions of the hKOR gene
were involved in the increase of hKOR transcription under DFO simulated hypoxia. The plasmid
containing two copies ofD (2-D) showed an extremely strong reporter activity, suggesting that 2
copies of the D region are acting synergistically. In summary, this study suggested that HIF may
play an important role in the upregulation ofhKOR message. However, we will need to repeat
these experiments to confirm these preliminary results in the near future.
HIF-I has many target genes; the most interesting would be the TGF and IGF genes
which are linked to cell proliferation and survival (Semenza et aI., 2003). IGF-I has been shown
to mediate neuroprotection in embryonic rat neurons, and prevents neuronal programmed cell
death (Vincent et aI., 2010). As stated before, the increase in glutamate in the neuronal cells
causes cell death (Dendorfer et aI., 2005). TGF-p has been able to protect hippocampal neurons
in vitro against short term exposure from glutamate (Alzheimer et aI., 2002). In addition, this
study also provided evidence and suggested that hKOR is a HIF target gene.
This study indicates that hKOR may play an important role in hypoxic condition using
hypoxic NMB cells model. Future experiments include the blocking ofHIF-1 with siRNA
strategy to observe if the downregulation of HIF will affect hKOR expression, and examining the
downstream effect of opioid receptors will be useful. It is also interesting to understand the
combinatory effect of putative HIF response elements on the expression of hKOR, which will
provide further information about the adaptive responses of human neuronaI cells under hypoxic
simulated condition.
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Conclusion

Using the human hypoxic neuronal cell model system we found that the treatment with
DFO, a hypoxic mimicking compound, resulted in an increase ofIDF·l rnRNA levels in the
surviving cells. Also, there were various influences on the expression of different opioid receptor
genes under hypoxia. The 24 hour treatment caused the decrease ofhMOR message level in the
surviving cells, but the hDOR expression showed no significant change. However, the hKOR
message increased in this hypoxic model system.
This study further demonstrated that not only that hKOR rnRNA level increased, but also
the expression ofhKOR protein increased significantly at 48 hour of treatment as compared to
control and the 24 hour treatment, which can be due to the translational regulation and protein
abundance. In addition, the preliminary results from the luciferase reporter assay suggested that
the 5' flanking regions of the KOR gene containing the functional HIF responsive elements,
which can playa role in hypoxia. Furthermore, the plasmid containing 2 copies ofHIF
responsive element of the D region showed an extremely strong activity, suggesting that D
region has an important role in hKOR regulation under hypoxia. Further studies, such as the
investigation of combinatory effect ofHIF responsive elements and signaling pathways
controlling the downstream effect under hypoxia, will provide the useful information to help us
understand the cellular adaptive response under hypoxia.
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